Incidence and Risk Factors for Development of Thrombocytopenia in Patients Treated With Linezolid for 7 Days or Greater.

Related Articles

Incidence and Risk Factors for Development of Thrombocytopenia in Patients Treated With Linezolid for 7 Days or Greater.

Ann Pharmacother. 2018 Jun 01;:1060028018783498

Authors: Rabon AD, Fisher JP, MacVane SH

PMID: 29911390 [PubMed - as supplied by publisher]